Advertisement

Topics

Companies Related to "A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy" [Most Relevant Company Matches] - Page: 4 RSS

20:52 EST 14th November 2018 | BioPortfolio

Here are the most relevant search results for "A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy" found in our extensive corporate database of over 50,000 company records.

Showing "Phase Randomized Double blind Placebo Controlled Dose Ranging" Companies 76–100 of 1,800+

Relevant

DelSiTech Ltd

Founded in 2001, DelSiTech Ltd is located in Turku Science Park in Turku, Finland.The company operates in the development and licensing of long-term controlled drug delivery implant, subcutaneous or intramuscular formulations.The unique controlled release DelSiTech™ technology based on amorphous silica is flexible and applicable for synthetic small molecules but especially for labile biopharmace...


Harvard Apparatus

Harvard Apparatus was founded in 1901 by Dr. William T. Porter of the Harvard Medical School. Harvard Apparatus developed a name not only for quality but also for innovation. Harvard Apparatus invented the mechanical syringe pump in the 1950s and introduced the first microprocessor controlled syringe pumps in the 1980s. Today Harvard Apparatus continues this tradition with the most advanced, easie...

PreScience Labs, LLC

PreScience is a developmental stage bio-pharmaceutical company focused on the development of anti-cancer drugs. It has successfully completed preclinical mechanistic, in vitro and animal testing using intra-arterial delivery of its proprietary drug PSL-001. The FDA approved immediate enrollment of a Phase I, dose-escalating study, which PreScience intends ...


Phase One Medical

Phase One Medical is a privately held medical device research and development company. The company is focused on early stage device development and small part design and manufacture. For more information on Phase One Medical, L.L.C. products and services e-mail the company at info@phase-one.us or visit the company’s web site at: www.phaseonemedical.co...

CET CANCER CENTER

California Endocurietherapy Cancer Center (CET) is the first brachytherapy only center in the United States.Founded by D Jeffrey Demanes M.D. in 1981.Dedicated solely to High Dose Rate brachytherapy (HDR) since 1991.Most experienced HDR brachytherapy center.A training destination for physicians and residents.HDR treatment protocol developmentInnovation in high dose rate brachytherapy and equipment...

Azaya Therapeutics Inc.

Azaya Therapeutics, Inc. is an oncology company focused on developing more effective cancer treatments through its novel nanotechnology platform. Azaya’s patented Protein Stabilized Liposomes™ (PSL) platform allows for high-dose delivery of potent cytotoxics with potentially lower side effects. ATI-1123, is a novel liposomal encapsulation of Doce...

Probably Relevant

Controlled Therapeutics (Scotland) Ltd

Controlled Therapeutics was founded in 1987 as a limited liability company organised under the laws of Scotland, and located at Peel Park Campus, 1 Redwood Place, East Kilbride, G74 5PB, Scotland. The company’s objective has always been to develop, manufacture and license pharmaceutical products based on patented drug delivery technologies

Advanced Biomedical Research Incorporated

Advanced Biomedical Research, Inc. (ABR) Corporate Headquarters is located in Pennington, New Jersey adjacent to the Princeton biopharmaceutical research corridor. ABR is a full service CRO offering an integrated package of customized services including clinical study protocol design, project management and study monitoring, quality assurance auditing, medical safety monitoring, biostatistics and...

Worldwide Clinical Trials

Accelerate Your Development Program with Pinpoint Therapeutic Focus and Complete Spectrum of Services Worldwide Clinical Trials is a global CRO that provides full-service drug development services to the pharmaceutical and biotechnology industries.   As one of the most innovative and scientifically-driven contract research organizations, we offer exceptionally strong clinical trial m...

CiTrials

At Clinical Innovations, our mission is to conduct Phase I-IV clinical trials in order to further the development of medications benefiting patients, communities, and physicians around the globe. Located in Southern California, CiTrials has the experience and expertise in performing Psychiatric and Internal medicine trials. From pediatric, first in human, single and multiple ascending dose, and...

DP Clinical

DP Clinical is a privately-held, minority-owned contract research organization (CRO) located in the I-270 Technology Corridor in Rockville, Maryland serving pharmaceutical and biotechnology clients. Providing our clients with monitoring, data management, analysis, and biostatistics for Phase I – IV clinical trials, DP Clinical has built a strong reputation for high standards of quality, data int...

Medifocus Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

GammaWest Brachytherapy

Brachytherapy is an advanced cancer treatment. The word "brachy" is Greek for "close by" and refers to placing radioactive seeds or sources directly in the tumor. This procedure gives physicians and patients the important advantage of applying a higher dose of radiation directly to the tumor while sparing healthy tissue and surrounding organs. Brachytherapy is a localized, precise, radiation treat...

Vindon

Vindon is engaged in the manufacture of environmental control products for the pharmaceutical industry, life sciences and food sectors, together with the provision of related services. The company provides products and services for the management of temperature, humidity and light, where controlled storage is required. Vindon is a leading provider of contr...

Medifocus, Inc.

Medifocus owns a patented microwave focusing technology platform the Adaptive Phased Array ("APA") system, which can precisely target and concentrate microwave energy to destroy cancer tumors without damaging healthy tissue when used alone or in conjunction with chemotherapy or radiation. The ability to target tumors with a precision controlled dose of hea...

Spaulding Clinical

Spaulding Clinical (www.spauldingclinical.com) is a Phase 1 Clinical Pharmacology Research Unit and Electrocardiography Core Lab located in West Bend, Wisconsin offering a full range of services. The company has extensive experience conducting TQT studies, first-in-human studies, multiple rising dose, bioavailability and bioequivalence, drug interaction, a...

Selexis SA and OSE Immunotherapeutics SA

Our ambition is to become a world leader in activation and regulation immunotherapies: OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focused on the development of innovative immunotherapies of activation and regulation in immuno-oncology, autoimmune diseases and transplantation. The company has a balanced portfolio ...

TOPICA Pharmaceuticals, Inc.

TOPICA Pharmaceuticals, Inc. is a privately held clinical research stage pharmaceutical company focused on developing luliconazole for the treatment of onychomycosis, or fungal infections of the nail. The company is focused on conducting the Phase 2b/3 SOLUTION Study, a robust dose finding and proof of efficacy trial with luliconazole in onychomycosis with...

PaxVax Inc.

PaxVax is a privately held specialty vaccine company founded in 2007. PaxVax is focused on traveler vaccines with an emerging pipeline in biodefense coupled with a social mission to ensure global access to its vaccines. PaxVax’s clinical-stage product portfolio includes an oral, single-dose cholera vaccine in Phase 3 clinical trials, a pandemic H5N1 i...

Caledon Laboratories Limited

Caledon Laboratories Ltd. is a Canadian company that specializes in the preparation of laboratory chemicals. We carefully produce more than 1,000 different reagents, solutions, and solvents for use in quality control, research and education. Our state of the art manufacturing facility is custom-designed for the purification of large volumes of organic solvents, the preparation of standardized solu...

Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals develops innovative therapeutics based on targets with established proofs of concept that are designed to provide significant advances over current treatments for cardiovascular disease and inflammation. The company has global development and commercialization agreements with two of the world's leading pharmaceutical companies collectively valued at about $1 billion in upfr...

Variation Biotechnologies, Inc.

VBI is an emerging leader in the innovative formulation, delivery and development of vaccines. The Company’s powerful, proprietary technology platforms enable thermostable IM and thermostable oral vaccine delivery, creating improved dose equivalent and the potential for dose sparing and adjuvanted vaccines, extending vaccine reach and coverage in established...

Biolex, Inc

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. The company is advancing a proprietary pipeline of product candidates including Locteron™, a next-generation controlled-release form of alfa interferon which enter...

Biolex, Inc.

Biolex Therapeutics applies its unique drug development capabilities and expertise to commercialize complex proteins and monoclonal antibodies that until now have been impossible or very expensive to develop through traditional means. The company is advancing a proprietary pipeline of product candidates including Locteron™, a next-generation controlled-release form of alfa interferon which enter...

Midway Pharmaceuticals

Midway Pharmaceuticals is an emerging pharmaceutical company focused on developing proprietary drugs for the treatment of gastrointestinal diseases. The company’s platform technology capitalizes on the finding that certain high molecular weight polymers, taken orally but not systemically absorbed, can inhibit the pathogenic behavior of bacteria in the...


More From BioPortfolio on "A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks